Characteristic | DLE (n = 15) | Controls (n = 30) |
---|---|---|
Intent of treatment, No. of treatments (%) | Â | Â |
Curative | 12 (80) | 24 (80) |
Palliative | 3 (20) | 6 (20) |
Anatomic target of radiotherapy, No. of treatments (%) | Â | Â |
Head and neck | 3 (20) | 6 (20) |
Prostate | 3 (20) | 6 (20) |
Breast | 2 (13) | 4 (13) |
Thorax | 2 (13) | 4 (13) |
Spine | 2 (13) | 4 (13) |
Bladder | 1 (7) | 2 (7) |
Brain | 1 (7) | 2 (7) |
Pelvis | 1 (7) | 2 (7) |
Radiotherapy technique, No. of treatments (%) | Â | Â |
External beam radiotherapy, 2-dimensional | 13 (87) | 28 (93) |
External beam radiotherapy, 3-dimensional | 1 (7) | 0 (0) |
Iodine brachytherapy | 1 (7) | 2 (7) |
Radiotherapy dose, median (range) | Â | Â |
Dose per fraction, Gy | 2.0 (1.2-8.0) | 2.0 (1.6-4.0) |
No. of fractions | 28 (1-50) | 30 (2-42)) |
Total dose, Gy | 52.8 (8.0-66.0) | 58.8 (8.0-66.6) |
Biologically equivalent dose, Gy, median (range) | Â | Â |
Gy3 | 31.8 (18.2-45.5) | 39.5 (24.3-45.5) |
Gy10 | 19 (5.6-13.9) | 12.3 (3.3-16.7) |
Chemotherapy before or after 60 d of radiotherapy | Â | Â |
No | 12 (80) | 23 (76) |
Yes | 3 (20) | 7 (24) |
Surgery before or after 60 d of radiotherapy | Â | Â |
No | 12 (80) | 23 (76) |
Yes | 3 (20) | 7 (24) |